Literature DB >> 11118043

Mutations of adenomatous polyposis coli and beta-catenin genes during progression of lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine in rats.

T Tsujiuchi1, M Tsutsumi, Y Sasaki, N Murata, Y Konishi.   

Abstract

In the present study, we investigated mutations of the adenomatous polyposis coli (APC) and beta-catenin genes to clarify possible molecular mechanisms underlying development of lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine (BHP) in rats. Male Wistar rats, 6 weeks of age, were given 2000 ppm BHP in drinking water for 12 weeks and then maintained without further treatment until sacrifice at week 25 DNA was extracted from paraffin-embedded tissues, and PCR-single-strand conformation polymorphism analysis, followed by nucleotide sequencing, was performed. No APC mutations were detected in 17 hyperplasias, but 2 of 15 adenomas (13.3%) and 8 of 20 adenocarcinomas (40.0%) showed changes within exon 1 to the mutation cluster region in exon 15. For beta-catenin, no mutations were detected in 17 hyperplasias, but 3 of 15 adenomas (20.0%) and 5 of 20 adenocarcinomas (25.0%) had alterations within or flanking codons corresponding to important phosphorylation sites. Immunohistochemical staining showed beta-catenin protein localized in the cell membranes in the surrounding normal-appearing lung and 216 hyperplasias and localized mainly in the cytoplasm and/or nucleus in 10 of 37 adenomas (27.0%) and 21 of 40 adenocarcinomas (52.5%). These results suggest that the APC-beta-catenin-T-cell factor signaling pathway is involved in the acquisition of growth advantage from adenomas to adenocarcinomas in BHP-induced rat lung carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118043

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Destabilization of heterologous proteins mediated by the GSK3β phosphorylation domain of the β-catenin protein.

Authors:  Yuhan Kong; Hongyu Zhang; Xian Chen; Wenwen Zhang; Chen Zhao; Ning Wang; Ningning Wu; Yunfeng He; Guoxin Nan; Hongmei Zhang; Sheng Wen; Fang Deng; Zhan Liao; Di Wu; Junhui Zhang; Xinyue Qin; Rex C Haydon; Hue H Luu; Tong-Chuan He; Lan Zhou
Journal:  Cell Physiol Biochem       Date:  2013-11-14

2.  Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma.

Authors:  Rex C Haydon; Andrea Deyrup; Akira Ishikawa; Robert Heck; Wei Jiang; Lan Zhou; Tao Feng; David King; Hongwei Cheng; Benjamin Breyer; Terrance Peabody; Michael A Simon; Anthony G Montag; Tong-Chuan He
Journal:  Int J Cancer       Date:  2002-12-01       Impact factor: 7.396

3.  Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity.

Authors:  Lan Zhou; Naili An; Rex C Haydon; Qixin Zhou; Hongwei Cheng; Ying Peng; Wei Jiang; Hue H Luu; Pantila Vanichakarn; Jan Paul Szatkowski; Jae Yoon Park; Benjamin Breyer; Tong-Chuan He
Journal:  Cancer Lett       Date:  2003-04-25       Impact factor: 8.679

4.  Involvement of mutation-based inhibition of beta-catenin phosphorylation at Ser33 in the malignant progression of lung (pre)neoplastic lesions induced by N-nitrosobis(2-hydroxypropyl)amine in male Fischer 344 rats.

Authors:  Maki Igarashi; Midori Yoshida; Manabu Watanabe; Toshiyuki Yamada; Takuya Sakurai; Yoshifumi Endo; Nozomi Miyajima; Akihiko Maekawa; Tsuneyuki Oikawa; Sumio Sugano; Dai Nakae
Journal:  Lung       Date:  2007-07-18       Impact factor: 3.777

5.  Long-term Pulmonary Responses to Quadweekly Intermittent Intratracheal Spray Instillations of Magnetite (Fe3O4) Nanoparticles for 52 Weeks in Fischer 344 Rats.

Authors:  Yukie Tada; Norio Yano; Hiroshi Takahashi; Katsuhiro Yuzawa; Hiroshi Ando; Yoshikazu Kubo; Akemichi Nagasawa; Akiko Inomata; Akio Ogata; Dai Nakae
Journal:  J Toxicol Pathol       Date:  2013-12-26       Impact factor: 1.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.